4//SEC Filing
Lalani Jzaneen 4
Accession 0001209191-09-000976
CIK 0001062216other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 5:14 PM ET
Size
9.3 KB
Accession
0001209191-09-000976
Insider Transaction Report
Form 4
Lalani Jzaneen
VP Legal Affairs
Transactions
- Disposition to Issuer
Common Stock
2009-01-05$0.61/sh−2,075$1,266→ 0 total - Disposition from Tender
Common Stock
2009-01-01$0.61/sh−16,063$9,798→ 0 total - Disposition to Issuer
Employee Stock Option (Right To Buy)
2009-01-05$0.06/sh−250,000$15,000→ 0 totalExercise: $0.55Exp: 2018-01-31→ Common Stock (250,000 underlying)
Footnotes (2)
- [F1]Represents shares purchased under the Issuer's Second Amended and Restated 2004 Employee Stock Purchase Plan.
- [F2]This option, which provided for quarterly vesting over four years commencing on the grant date, was canceled in connection with the Issuer's merger with 900 North Point Acquisition Corporation on January 5, 2009. In exchange, the Reporting Person received a cash payment of $15,000, which represents the difference between the exercise price of the option and the offer price of $0.61 per share multiplied by the number of shares underlying the option.
Documents
Issuer
MEMORY PHARMACEUTICALS CORP
CIK 0001062216
Entity typeother
Related Parties
1- filerCIK 0001293763
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 5:14 PM ET
- Size
- 9.3 KB